Holen Sie sich die Stockscreener-App
10.74
0.00%
0.000100
Handel nachbörslich:
10.74
-0.000100
-0.00%
Schlusskurs vom Vortag:
$10.74
Offen:
$10.75
24-Stunden-Volumen:
1,319
Relative Volume:
0.01
Marktkapitalisierung:
$207.38M
Einnahmen:
-
Nettoeinkommen (Verlust:
$6.21M
KGV:
37.88
EPS:
0.2835
Netto-Cashflow:
$-682.00K
1W Leistung:
+0.23%
1M Leistung:
-0.09%
6M Leistung:
+1.71%
1J Leistung:
+4.07%
1-Tages-Spanne:
$10.74
$10.75
1-Wochen-Bereich:
$10.71
$10.75
52-Wochen-Spanne:
$10.32
$10.80
Translational Development Acquisition Corp Stock (TDAC) Company Profile
Firmenname
Translational Development Acquisition Corp
Sektor
Branche
Telefon
(413) 204-2769
Adresse
52 E 83RD ST., NEW YORK
Compare TDAC vs LION, XXI, UMAC, CCXI, DMII
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TDAC
Translational Development Acquisition Corp
|
10.74 | 207.38M | 0 | 6.21M | -682.00K | 0.2835 |
LION
Lionsgate Studios Corp
|
13.85 | 3.93B | 2.63B | -175.60M | 11.40M | -0.7173 |
XXI
Twenty One Capital Inc
|
5.02 | 1.71B | 0 | 4.35M | 456.40K | 0.3397 |
UMAC
Unusual Machines Inc
|
19.67 | 933.42M | 17.25M | -5.64M | -40.16M | -0.3337 |
CCXI
Churchill Capital Corp Xi
|
14.65 | 826.03M | 0 | 0 | 0 | 0.0647 |
DMII
Drugs Made In America Acquisition Ii Corp
|
10.09 | 642.10M | 0 | 8.58M | -1.11M | 0.134 |
Translational Development Acquisition Corp Stock (TDAC) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2021-09-21 | Eingeleitet | Northland Capital | Outperform |
Translational Development Acquisition Corp Aktie (TDAC) Neueste Nachrichten
Price to sales forward of Translational Development Acquisition Corp. – NASDAQ:TDACW - TradingView
Enterprise value to revenue forward of Translational Development Acquisition Corp. – NASDAQ:TDACW - TradingView
Price to earnings forward of Translational Development Acquisition Corp. – NASDAQ:TDACW - TradingView
Wolverine Asset Management LLC Reduces Stake in Translational De - GuruFocus
Price to sales forward of Translational Development Acquisition Corp. – NASDAQ:TDACU - TradingView
Clearway Energy Reports Lower-Than-Expected Wind & Solar Generation in 2Q 2026 Due to El Niño Impacts 1 - Minichart
Wolverine Asset Management (TDAC) reports 4.89% stake in Class A shares - Stock Titan
If You Invested $1,000 in Translational Development Acquisition Corp (TDAC) - Stock Titan
Price to sales forward of Translational Development Acquisition Corp. – BOATS:TDACU - TradingView
Price to sales forward of Translational Development Acquisition Corp. – NASDAQ:TDAC - TradingView
Number of shareholders of Translational Development Acquisition Corp. – NASDAQ:TDACU - TradingView
Translational Development Acquisition Corp. and ProLogium Advance Merger with SEC F-4 Filing, Marking Key Step Forward - Minichart
TDAC Advances ProLogium De-SPAC with SEC Filing - TipRanks
TDAC says ProLogium files Form F-4, advancing planned de-SPAC merger - TradingView
ProLogium–TDAC (NYSE: TDAC) merger advances with initial Form F-4 filing - Stock Titan
ProLogium files F-4 with SEC for TDAC merger transaction - Investing.com
ProLogium files F-4 with SEC for TDAC merger transaction By Investing.com - Investing.com Canada
TDAC Announces ProLogium's Filing of F-4 As Continuing Momentum Towards Merger - Yahoo Finance
TDAC (Translational Development Acquisition Corp) Holds Near Support After Slight DipPercent Above MA - dars.gov.et
Translational Development Acquisition Corp. (TDAC) Hovers Near NAV as SPAC Trades in Tight RangeSeasonality Effect - dars.gov.et
ProLogium (TDAC) on Bloomberg; Dunkirk ramp-up targeted Q2 2029 - Stock Titan
Translational Development Acquisition Corp. (TDAC) Wavers Near Support Amid Light TradingVolume Breadth - dars.gov.et
Price to sales forward of Translational Development Acquisition Corp. – BOATS:TDACW - TradingView
Enterprise value to EBITDA forward of Translational Development Acquisition Corp. – BOATS:TDACW - TradingView
Price to earnings forward of Translational Development Acquisition Corp. – BOATS:TDACW - TradingView
Enterprise value to EBIT forward of Translational Development Acquisition Corp. – BOATS:TDACW - TradingView
Enterprise value to revenue forward of Translational Development Acquisition Corp. – BOATS:TDACW - TradingView
TDACW (TDACW) Valuation: PE, PB & Fair Value Analysis - TradingKey
TDAC Shareholders Back SPAC Extension Amid ProLogium Deal - The Globe and Mail
TDAC Shareholders Back ProLogium Merger Extension, Retaining $156.8M in Trust and 85% Share Support - Minichart
Form 8K Translational Development Unit For: 23 June By Investing.com - Investing.com India
TDAC reports 85% shareholder retention, $156.8M remaining in trust after extension vote - TradingView
Translational Development (TDAC) files redemption update on ProLogium deal (TDAC) - Stock Titan
TDAC (NYSE: TDAC) retains $156.8mm in trust as most holders stay - Stock Titan
ProLogium (TDAC) cites 2.4M cells delivered and Dunkirk gigafactory timeline - Stock Titan
TDACTranslational Development Acquisition Corp Options - Finviz
MTNE Stock Price and Chart — NYSE:MTNE - TradingView
SPAC Defies Odds: Investor Bet on ProLogium’s Battery Tech Powers Merger - BriefGlance
TDAC retains $156.8 million in trust as 85% reject redemption By Investing.com - Investing.com Australia
TDAC Announces Successful Shr Redemption Results in Connection With Extension Vote - Moomoo
TDAC retains $156.8 million in trust as 85% reject redemption - Investing.com
TDAC Announces Very Successful Share Redemption Results in Connection with Extension Vote - Barchart.com
ProLogium, Elysian MoU explores aviation batteries (TDAC) - Stock Titan
Translational Development Acquisition Corp. (TDAC) Holds Steady at $10.75 as SPAC Trading Remains Range-BoundVolatility Stop - dars.gov.et
DYNC PE Ratio & Valuation, Is DYNC Overvalued - Intellectia AI
ProLogium to list on Nasdaq via TDAC merger at $3.8B valuation - MSN
Translational Development Acquisition shareholders approve extension for business combination By Investing.com - Investing.com Australia
Translational Development Acquisition shareholders approve extension for business combination - Investing.com UK
Translational Development Acquisition Wins Approval for SPAC Extension - TipRanks
TDAC (NASDAQ: TDAC) wins shareholder approval to extend SPAC deal deadline to 2027 - Stock Titan
ProLogium’s public listing is set to close in the second half of 2026 — valuing the only mass-production solid-state battery line on Earth at about $3.8 billion - MSN
Finanzdaten der Translational Development Acquisition Corp-Aktie (TDAC)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.96%
0.15%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):